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Heart enhancers with deeply conserved regulatory
activity are established early in zebrafish
development
Xuefei Yuan1,2,3, Mengyi Song1,2,3, Patrick Devine4,5, Benoit G. Bruneau4,6,
Ian C. Scott2,3 & Michael D. Wilson 1,3
During the phylotypic period, embryos from different genera show similar gene expression
patterns, implying common regulatory mechanisms. Here we set out to identify enhancers
involved in the initial events of cardiogenesis, which occurs during the phylotypic period. We
isolate early cardiac progenitor cells from zebrafish embryos and characterize 3838 open
chromatin regions specific to this cell population. Of these regions, 162 overlap with con-
served non-coding elements (CNEs) that also map to open chromatin regions in human.
Most of the zebrafish conserved open chromatin elements tested drive gene expression in
the developing heart. Despite modest sequence identity, human orthologous open chromatin
regions recapitulate the spatial temporal expression patterns of the zebrafish sequence,
potentially providing a basis for phylotypic gene expression patterns. Genome-wide, we
discover 5598 zebrafish-human conserved open chromatin regions, suggesting that a diverse
repertoire of ancient enhancers is established prior to organogenesis and the phylotypic
period.
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The developmental hourglass model predicts a phylotypicstage during mid-embryogenesis when species within thesame phylum display the greatest level of morphological
similarities1,2. The hourglass model is also supported by com-
parative transcriptomic studies that demonstrated that the most
conserved gene expression patterns occur at the phylotypic
stage3–5. The idea that conserved phylotypic gene expression is
established through conserved enhancers is supported by several
comparative epigenomic studies6–9. While most molecular studies
of the phylotypic period have focused on whole embryos, recent
evidence suggests that the exact developmental timing of maximal
conservation varies in a tissue-specific manner8. We are only
beginning to understand how conserved transcriptional programs
for individual developmental lineages are set up prior to the
phylotypic stage.
The heart, derived from the cardiac mesoderm, is the first
organ formed during embryogenesis. Heart development is
orchestrated by conserved cardiac transcription factors (TFs)
binding to cis-regulatory elements (CREs)10,11. Crucial cardiac
specification events occur during early embryogenesis12–15. For
example, distinct subtypes of mouse cardiac progenitors emerge
within the gastrula stage preceding the expression of the cano-
nical cardiac progenitor marker Nkx2.5, long before any organ
structure is formed12–14. However, how this potential early car-
diac specification is controlled by enhancer elements, and the
extent to which this process is evolutionarily conserved, is not
known.
Heart enhancers have been extensively characterized in studies
utilizing genome-wide profiling techniques including chromatin
immunoprecipitation followed by DNA sequencing (ChIP-seq)16–21,
computational predictions22,23, and in vivo validation in mouse and
zebrafish embryos16,17,19,22,23. To date, the majority of in vivo heart
enhancer discoveries and validation experiments were performed in
embryos following establishment of the heart chamber structures or
in adult hearts16,17. In vitro differentiation of embryonic stem cells
(ESCs) into cardiac progenitors have also yielded insights into the
early cardiac development and have enabled the discovery of cardiac
enhancers18,20,21. However, more work is needed to identify the
CREs that regulate the early differentiation of mesoderm progenitors
to cardiac lineages in the context of the developing embryo.
Despite the highly conserved cardiac TFs necessary for heart
development, heart enhancers identified at mouse E11.5 show
limited phylogenetic conservation compared to brain enhancers
identified at the same developmental stage8,16. However, analysis
of putative enhancers in mesoderm cells, derived from embryonic
stem cells, show higher evolutionary constraint than the enhan-
cers identified after organogenesis8. This suggests that the reg-
ulatory elements that establish the conserved cardiac
transcriptional program may exist at the initial stages of heart
development, presumptively during the time window from naive
mesoderm to cardiac progenitors.
Here, we set out to discover enhancers that are active in cardiac
progenitor cells prior to the expression of the cardiac progenitor
marker Nkx2.5. We generate a zebrafish GFP reporter line driven
by a mouse Smarcd3 enhancer (Smarcd3-F6) that is active in early
gastrulating mouse mesoderm12, in order to enrich for early
zebrafish cardiac progenitors. We profile gene expression and the
accessible chromatin landscape of GFP positive cells using single
cell mRNA-seq, the assay for transposase-accessible chromatin
using sequencing (ATAC-seq), lineage tracing, and RNA in-situ
hybridization, both in wild-type embryos and following knock-
down of the essential cardiac transcription factors Gata5/6.
Results from these experiments indicate that we have purified a
population of cells enriched for cardiac progenitors. Using direct
and indirect DNA alignments24,25, we identify accessible chro-
matin regions shared between zebrafish and human. We find that
these conserved accessible chromatin elements were highly
associated with developmental transcription factors that are
regulated by polycomb repressive complex 2 (PRC2). We confirm
the cardiac activity and functional conservation of many anciently
conserved open chromatin regions using in vivo reporter assays.
In sum, our study identifies a set of conserved cardiac enhancers
established prior to the phylotypic period, before the heart and
other organ primordia appear, potentially providing a basis for
common gene expression patterns across genera. Furthermore,
we uncover ~ 6000 anciently conserved open chromatin regions
that likely serve as enhancers for other cell lineages.
Results
Isolation of zebrafish cardiac progenitor cells. To examine the
earliest events that contribute to cardiac lineage specification in
zebrafish, we needed a means to isolate early cardiac progenitor
cells in vivo. To identify a zebrafish marker that could drive GFP
expression in cardiac progenitor cells prior to nkx2.5 expression,
we tested a recently described early mouse cardiac enhancer,
Smarcd3-F612 in our zebrafish model. Lineage tracing experi-
ments demonstrated that this enhancer labeled cardiac progenitor
cells prior to Nkx2.5 expression in mouse embryos12. We also
found that the Smarcd3-F6 region was enriched for the active
enhancer mark H3K27ac and contains a CRE co-bound by sev-
eral conserved cardiac TFs (GATA4, NKX2.5, TBX5) in mouse
ESC differentiated cardiac precursors (CP) and cardiomyocytes
(CM)18,21 (Supplementary Fig. 1a).
To test if the Smarcd3-F6 enhancer functions as an early
marker of cardiac progenitors in zebrafish, we generated a Tg
(Smarcd3-F6:EGFP) transgenic line (Fig. 1a). Due to the lag time
between transcription and GFP accumulation, we conducted
RNA in-situ hybridization against gfp in order to detect
enhancer activity at early developmental times. We found that
gfp signal could be detected as early as 6 h post-fertilization (hpf)
along the embryonic margin (Fig. 1b), which contains
mesendodermal progenitors including future cardiac cells26.
Over the course of gastrulation, GFP positive cells migrated to
encompass positions in the anterior and posterior lateral plate
mesoderm (ALPM and PLPM) (Fig. 1b, c). Co-immunostaining
comparing Tg(Smarcd3-F6:EGFP) and Tg(nkx2.5:ZsYellow)
expression indicated that the Smarcd3-F6 enhancer marked
almost all cardiac mesoderm expressing nkx2.5 at early somite
stages (13 hpf) (Fig. 1d). Tg(Smarcd3- F6:CreERT2) lines were
generated to trace the fate of Smarcd3-F6 labeled cells. By
crossing Tg(Smarcd3-F6:CreERT2) to a Tg(βactin2-loxP-dsRed-
loxP-GFP) reporter line, we found that following 4-
hydroxytamoxifen (4-HT) addition at 8 hpf, cells labeled by
the Smarcd3-F6 enhancer contributed to heart formation
(Supplementary Fig. 1). Although the Smarcd3-F6 enhancer
shows limited mammalian, and no zebrafish sequence conserva-
tion (Supplementary Fig. 1a), the early labeling of cardiac
lineages in zebrafish indicated that this enhancer would allow us
to isolate a cell population enriched for cardiac progenitors.
To further characterize the population marked by the Smarcd3-
F6 enhancer, we conducted bulk mRNA-seq and ATAC-seq at 10
hpf on Smarcd3-F6 labeled (GFP+) and unlabeled (GFP−) cells
(Fig. 1e). mRNA-seq revealed 316 genes differentially expressed
between the GFP+ and GFP− population (FDR < 0.05, absolute
log2FC > 1). Known cardiac (gata5, nkx2.7, tbx20, hand2) and
endoderm (sox32, sox17) markers showed significantly higher
expression in Smarcd3-F6 labeled cells while ectoderm and axial
mesoderm genes were relatively depleted (Fig. 1f). Consistent
with these results, genes showing higher expression in the GFP+
population were enriched for processes related to cardiovascular
and endoderm development, whereas genes enriched in
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GFP− cells were enriched for those involved in nervous system
development (Fig. 1g).
To further dissect the putative cardiac progenitors within the
10 hpf Smarcd3-F6 labeled population, we performed single-cell
mRNA-seq on 96 GFP+ cells. The average of all single-cell
transcriptomes correlated well with the bulk mRNA-seq results
(Pearson correlation R= 0.93, P < 2.2e–16) (Supplementary
Fig. 2a). Unsupervised clustering using genes differentially
expressed between GFP+ and GFP− populations grouped cells
into three broad clusters, which represented putative endodermal
(gata5+, sox17+, sox32+), mesodermal (gata5+, sox17−, sox32−)
and ectodermal (gata5−, sox2+, sox3+) populations (Supplemen-
tary Fig. 2b). Within the mesoderm cluster, we could identify a
potential cardiac subgroup co-expressing the known cardiac
genes gata5, hand2, tbx20, and tmem88a (Supplementary Fig. 2b,
c). Together, our transcriptome analyses demonstrated that cells
labeled by the Smarcd3-F6 enhancer are enriched for cardiac
lineages, with a putative cardiac progenitor population apparent
by as early as 10 hpf.
ATAC-seq analysis of zebrafish cardiac progenitor cells. Open
chromatin profiles often identify the genomic regions where TFs
and their co-factors bind and function27. Using ATAC-seq, we
detected 155,879 open chromatin regions (ATAC-seq peaks) in
the GFP+ population and 153,777 in the GFP− population. After
conducting differential analysis, we found most ATAC-seq peak
regions (n= 195,466) shared similar ATAC-seq signals in both
GFP+ and GFP− populations. 5471 peaks showed significant
quantitative differences (Fig. 2a) with 3838 peaks specifically
increased in Smarcd3-F6 labeled cells (‘GFP+ specific’), and 1633
peaks specifically increased in unlabeled cells (‘GFP− specific’)
(Supplementary Data 1).
Our ATAC-seq peaks significantly overlap with active
chromatin marks found at promoters (H3K4me3, P= 0.001,
permutation test by GAT28) and enhancers (H3K27ac, P= 0.001;
H3K4me1, P= 0.001, permutation test by GAT28) that were
previously identified from ChIP-seq experiments on whole
zebrafish embryos of similar stages6. We found that 69% of
accessible zebrafish regions did not overlap with active chromatin
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marks (Supplementary Fig. 3a). The prevalence of open
chromatin regions with low levels of active chromatin marks
has been readily observed in human cell lines and associated with
a signature of motif-dependent binding characteristic of repres-
sive chromatin states29. It is likely that the lack of overlap of our
accessible chromatin regions with active chromatin marks
obtained from whole embryos will involve such regions in
addition to being due to technical reasons such as having purified
a small subset of cells away from the bulk embryo prior to ATAC-
seq.
Overall both the GFP+ specific and GFP− specific open
chromatin regions were depleted for proximal promoter (GFP+:
adjusted P= 1.83e–21, GFP-: adjusted P= 6.70e–15, Fisher’s
exact test, two-sided) and exonic regions (GFP+: adjusted P=
3.51e–17, GFP−: adjusted P= 4.81e–11, Fisher’s exact test, two-
sided) and enriched for introns (GFP+: adjusted P= 7.35e–12,
GFP−: adjusted P= 1.00e–10, Fisher’s exact test, two-sided) as
compared to the genomic distribution of all ATAC-seq peaks
(Supplementary Fig. 3b). Using the enrichment tool GREAT30,
we found that the GFP+ specific open chromatin regions were
enriched for heart development-related processes, based on
proximity to genes (heart morphogenesis: FDR= 1.09e–18,
embryonic heart tube development: FDR= 8.91e–17, binomial
test, Fig. 2b). GFP− specific open chromatin regions were
enriched for metabolic, gene expression and neural development-
related processes (regulation of primary metabolic process:
FDR= 5.60e–89, regulation of transcription, DNA-dependent:
FDR= 1.40e–86, nervous system development: FDR= 1.35e–75,
binomial test, Fig. 2b). Overall, the transcriptional profiles and
open chromatin regions enriched in the GFP+ and GFP−
specific populations further indicate that the Smarcd3-F6
enhancer marks cardiac progenitor cells.
We then asked which TF motifs were overrepresented in GFP+
specific peaks. We found that GATA motifs showed the strongest
enrichment, consistent with the crucial roles GATA factors play
in heart and endoderm development31–34 (Fig. 2c). In contrast,
GFP- specific peaks were most highly enriched for SOX motifs
(Fig. 2c). Like Gata4 and Gata6 in mice33,34, gata5 and gata6 play
redundant but critical roles in zebrafish heart formation31,32. To
test if the activity of the Smarcd3-F6 enhancer is regulated by
Gata5 and Gata6 in zebrafish, we performed gata5 and gata6
knock-downs by injecting previously validated morpholinos32
into Tg(Smarcd3-F6: EGFP) embryos. Supporting our motif
enrichments, we found that Smarcd3-F6 enhancer activity
requires Gata5 and Gata6 function (Fig. 2d). In contrast,
knocking down an early active SOX transcription factor
(Sox32)35 did not ablate the GFP signal (Fig. 2d).
Comparative analyses reveal conserved accessible chromatin.
To identify regions of open chromatin that are conserved between
zebrafish and human, we used two well-defined conserved non-
coding element (CNE) datasets, zCNE24 and garCNE25. Both of
these two resources contain conserved regions identified using
direct alignment and indirect homology bridged by intermediate
species (Fig. 3a and Supplementary Table 1). We associated
zebrafish ATAC-seq peaks to CNEs if they overlapped a
zebrafish-human or zebrafish-mouse CNE. Most accessible
chromatin-associated CNEs (~ 70%) were fully contained within
ATAC-seq peaks. On average 30% of the length of these ATAC-
seq peaks were comprised of CNEs. Within a total of 200,937
ATAC-seq peaks, we found 6294 (3.1%) or 6047 (3.0%) shared
sequence conservation with human or mouse respectively (see
Methods, Supplementary Fig. 3c and Supplementary Table 2 for
details). Of these 6294 zebrafish-human ATAC-seq peaks, 176
were GFP+ specific, and 264 were GFP− specific.
We found that GFP− specific peaks were ~ 4 times more
enriched for conserved regions than the GFP+ ones (P=
1.40e–46 using human CNEs; Chi-square test, two-sided)
(Fig. 3a). Previous work has shown that 30–45% of forebrain,
midbrain and limb enhancers overlapped regions of extremely
high sequence constraint, in contrast to only ~ 6% of cardiac
enhancers16. Given that GFP+ and GFP− populations were
enriched for cardiac and brain lineages respectively (Fig. 1f), our
observations were consistent with previous finding8,16.
Comparing genomic features (e.g., TF binding, chromatin
accessibility, histone modifications) between species is a poten-
tially powerful way to identify conserved regulatory function
within alignable sequences for specific tissues or cell types36–41.
For ATAC-seq peaks overlapping CNEs, we asked if the
orthologous human or mouse CNEs also contained accessible
chromatin according to DNase I hypersensitivity sites (DHS)
reported by ENCODE342 (Fig. 3b). We refer to these conserved
accessible chromatin regions connected through CNEs as aCNEs.
We found that the majority of the zebrafish ATAC-seq peaks
overlapping zebrafish-human or zebrafish-mouse CNEs were
classified as aCNEs (89% for human (5598/6294) and 79% (4747/
6047) for mouse; Fig. 3b, c). Overall ~ 3% of the total zebrafish
ATAC-seq peaks were identified as aCNEs that are shared
between zebrafish and human, or zebrafish and mouse. On
average, one zebrafish aCNE corresponded to 1.6 human and or
1.4 mouse aCNEs (Supplementary Fig. 3c, see Methods for
details)
As aCNEs were derived from CNE datasets, in which all coding
sequences had been carefully excluded24,25, we found that aCNEs
were depleted for exonic regions (0.78% versus 4.7%, adjusted
P= 3.95e–50, Fisher’s exact test, two-sided) and were enriched
for intronic regions (25.0% versus 21.7%, adjusted P= 5.15e–07,
Fisher’s exact test, two-sided) compared to all ATAC-seq peaks.
We did not see an enrichment for promoter regions in aCNEs
compared to all ATAC-seq peaks (9.34% versus 9.42%, adjusted
P= 1, Fisher’s exact test, two-sided). While ATAC-seq peaks at
promoters were more conserved than those not at promoters
(P= 7.82e–289, Wilcoxon test, two-sided), promoter aCNEs did
not show higher sequence constraint than non-promoter aCNEs
(P= 0.19, Wilcoxon test, two-sided) (Supplementary Fig. 3d).
We asked whether any genomic features could distinguish
aCNEs from bulk open chromatin regions. First, we found that
conserved ATAC-seq peaks had a wider boundary (average 706
bp compared to 475 bp, P= 0.001; permutation test), stronger
open chromatin signals (P= 2.84e–271; Wilcoxon test, two-
sided) and slightly higher GC content (average 46% compared to
44%, P= 0.001; permutation test) than the bulk zebrafish ATAC-
seq peaks (Supplementary Fig. 3e, f). When we separated
promoter and non-promoter aCNEs for analysis, we observed
similar results regarding interval length, GC content and open
chromatin signal intensity (Supplementary Fig. 3e, f).
We compared our aCNEs to ultraconserved non-coding
elements in the human genome43, which were defined as
sequence elements with no mismatches for at least 200 base
pairs between orthologous regions in the human, rat and mouse
genomes. While 30% of ultraconserved elements overlap human
aCNEs, only 3% of the aCNEs overlap ultraconserved elements
(Supplementary Data 2). The fact that nearly 40% (2228/5598 for
zebrafish-human aCNEs) of the aCNEs were found using indirect
alignments indicates that many of these ancient aCNEs show
limited sequence conservation and would likely have been
overlooked using standard multiple genome alignment methods.
aCNEs drive expression in the developing heart. To gain
insights into the cardiac enhancer activity of aCNEs, we
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compared the 281 GFP+ human aCNEs to putative heart
enhancers predicated using curated epigenomic data22. We found
a significant overlap between them (78/281, P= 1.68e–3, Fisher’s
exact test, two-sided) when using all human DNase I sites as
background. We next examined elements tested in the VISTA
enhancer database44, which is the most comprehensive database
of functionally validated enhancers (2017/07/29 release;
https://enhancer.lbl.gov/). When we took a global view of all
aCNEs from the human perspective, we found roughly 11% (958/
8866) of human aCNEs were included in the VISTA Enhancer
Browser. While less than 35% of the human regions (953/2787)
profiled by VISTA were functionally validated as positive
enhancers, two thirds of human aCNEs (640/958) tested were
reported as positive enhancers, indicating a significant
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enrichment of active developmental enhancers amongst aCNEs
(P= 9.02e–26, Fisher’s exact test, two-sided).
To determine if some conserved open chromatin elements are
bound by cardiac TFs during heart development, we collected
published ChIP-seq and ChIP-exo data for GATA4, NKX2.5,
TBX5, HAND2, MEF2A, and SRF conducted in mouse
embryonic hearts or cardiac cell types19,21,45,46 (Supplementary
Data 3). We found that among the 134 GFP+ specific ATAC-seq
peaks that were aCNEs shared with mouse, 49 (37%) are bound
by at least one cardiac TF at the orthologous regions of mouse
genome and 34 (25%) are CREs that are bound by more than one
cardiac TF (Supplementary Data 2). In contrast, cardiac TF
binding was rarely observed in GFP− specific open chromatin
regions (Supplementary Fig. 3f and Supplementary Data 2).
To assess the in vivo function of the GFP+ specific aCNEs, we
used a transgenic reporter assay to test their activity during
zebrafish embryonic development (Fig. 3c). The regions we
selected included both direct (13 regions) and indirect (8 regions)
alignments between zebrafish and human (Supplementary
Data 4). We cloned the 21 zebrafish regions into a Tol2-based
GFP enhancer detection vector and injected the constructs into
zebrafish embryos (Fig. 3c). We found that 18/21 regions drove
heart expression in at least 30% of the F0 embryos injected
(Supplementary Fig. 4), suggesting that they are active enhancers
in embryonic heart development. Within this set of 18 enhancers,
11 zebrafish aCNEs (ZaCNEs) were located near known cardiac
genes, nine of which overlapped the experimentally determined
binding sites (ChIP-seq peaks) of one or more cardiac TFs
(GATA4, NKX2.5, TBX5, HAND2, MEF2A, and SRF) in mouse
hearts or cardiac cell types19,21,45,46 (Supplementary Data 4).
Four of the seven selected ZaCNEs with no known cardiac gene
association had experimentally determined binding sites (ChIP-
seq peaks) of one or more cardiac TF (Supplementary Data 4).
We raised stable transgenic lines for the 18 ZaCNEs that passed
the 30% threshold in the F0 assays, to verify their cardiac activity
(Fig. 3c). We obtained multiple independent alleles for all
ZaCNEs except for ZaCNE18 for which only one transgene
germline carrier was identified (Supplementary Data 4). Despite
the random transgene integration mediated by the Tol2
transposon system, we observed consistent GFP expression in
hearts in multiple alleles of the same enhancer lines for 15/17
ZaCNEs, with ZaCNE4 and ZaCNE7 being the exceptions
(Supplementary Fig. 5). We also assayed the presumptive
phylotypic period (24 hpf) and found that 16/18 drove expression
in the linear heart tube (Supplementary Fig. 5e). These results
from stable transgenic embryos demonstrated high accordance
with those obtained from the F0 generation.
We classified the heart expression observed in the ZaCNE
transgenic lines into 4 major categories (Fig. 3d and Supplemen-
tary Fig. 5a). Some heart enhancers broadly labeled all heart
structures (Category I), while others showed specific or enhanced
expression in the ventricle (category II), atrioventricular canal
(category III) or outflow tract (category IV) (Fig. 3d and
Supplementary Fig. 5). These results confirmed the diverse
expression driven by aCNEs and suggested that they may play
distinct roles in regulating heart gene expression.
We asked if certain motifs were enriched in each enhancer
category. With the exception of category III (atrioventricular
canal), which only contains two sequences, enriched motifs were
identified in all other categories. GATA, SMAD, RAR/RXR,
ZNF263, and RREB1 motifs were found to be enriched in more
than one enhancer category, suggesting that they may represent
shared features of early cardiac enhancers (Supplementary
Fig. 5b). Category IV (outflow tract enhancers) had the most
distinct motif signature, with FOX (FOXO1, FOXP1, FOXK1 etc.)
and homeobox (HOXA2, EMX2, PDX1, etc.) motifs showing
strong enrichment (Supplementary Fig. 5b). Interestingly, Foxp1
has been shown to be required for outflow tract morphogenesis47
aCNEs share conserved early cardiac activities. We next aimed
to determine if human-zebrafish orthologous aCNEs were func-
tionally conserved with respect to their ability to control spatial-
temporal gene expression patterns. We chose four aCNEs near
the essential cardiac genes hand2/HAND2 (aCNE1), tbx20/TBX20
(aCNE20) and mef2cb/MEF2C (aCNE5, aCNE19). All of these
zebrafish sequences drove robust and specific heart expression in
stable transgenic lines (ZaCNE1, ZaCNE5, ZaCNE19, ZaCNE20)
(Fig. 4a, b and Supplementary Fig. 6a, b).
When tested in vivo, the four orthologous human
aCNE (HaCNE) sequences also drove GFP expression in the
hearts of zebrafish transgenic lines, with 3 of them (HaCNE1,
HaCNE5, HaCNE20) demonstrating activities similar to that of
their zebrafish orthologs (Fig. 4a, b and Supplementary Fig. 6a).
At 48 hpf, the GFP expression in the four human aCNE
transgenic lines was seen in both chambers and would be
classified as pan-cardiac enhancers (category I), but we noticed
that the human sequences tended to drive weaker or more mosaic
expression than their zebrafish orthologous sequences (Fig. 4a, b
and Supplementary Fig. 6a, b).
Due to the long perdurance of GFP protein, we next used gfp
RNA in-situ to characterize the spatiotemporal dynamics of the
aCNE activity. We found that both aCNE1 and aCNE20 pairs
were active in cardiac lineages at early somite stages (13 hpf, prior
to formation of the linear heart tube), 24 hpf, as well as 48 hpf
(Fig. 4c, d). Despite marking a broad population within the
ALPM (cardiac domain) at 13 hpf, we found that orthologous
pairs of enhancers labeled anatomical subregions of the heart in a
similar manner at 48 hpf (Fig. 4c, d). The two ZaCNE1 and
HaCNE1 enhancers both labeled ventricles and the inner
curvatures of atria (Fig. 4c). For the aCNE20 orthologs, the
strongest activity of both was seen in the inner curvature of
ventricles and atrioventricular canal regions (Fig. 4d).
Our motif enrichment analyses suggested that GATA factors
act as important regulators in the GFP+ population. Within
GFP+ specific zebrafish aCNEs conserved with human, 66%
(107/162) have at least one GATA motif and ~ 30% (52/162) have
more than one GATA motif (Supplementary Data 5). In contrast,
while using the same threshold, no significant GATA motifs were
found in the conserved GFP− specific zebrafish aCNEs
(Supplementary Data 5). To test the functional importance of
the GATA motif in aCNEs, we mutated an aligned GATA motif
within zebrafish and human aCNE1 regions (near the hand2/
HAND2 locus) and compared their activities with that of the
wild-type sequences (Supplementary Fig. 6c). In F1 stable
transgenic lines, we found that both zebrafish and human
aCNE1 sequences with mutated GATA motif drove much weaker
GFP expression in zebrafish hearts compared to the wild-type
sequences (Supplementary Fig. 6c).
These results together demonstrate that despite sequence
divergence between human and zebrafish aCNEs, we have
identified a number of conserved accessible chromatin elements
that share conserved spatiotemporal, GATA-dependent activities
during the early stages of heart development.
aCNEs are enriched for lineage-specific enhancers. Functional
enrichment analysis by GREAT revealed that aCNEs were sig-
nificantly associated with genes encoding DNA binding proteins,
with the highest enrichment being the homeodomain proteins
(GO:0043565, sequence-specific DNA binding: FDR= 0;
IPR009057, Homeodomain-like: FDR= 0; binomial test). Sup-
porting the role of aCNEs as developmental enhancers, we
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observed that these regions were also highly enriched for genes
regulated by PRC2 (MSigDB Perturbation, Set ‘Suz12 targets’:
FDR= 0, Set ‘Eed targets’: FDR= 0; binomial test). To gain more
insight into lineage-restricted functions of aCNEs, we compared
the human aCNEs orthologous to our GFP+ specific and GFP−
specific zebrafish ATAC-seq peaks. Although human aCNEs
specific to the GFP+ and GFP− populations both showed sig-
nificant enrichments for PRC2 target genes and homeobox
transcription factors, only a minority of PRC2 regulated genes
were associated with both GFP+ and GFP− aCNEs, indicating
that these two sets of aCNEs may be involved in distinct devel-
opmental processes (Fig. 5a and Supplementary Fig. 7).
To characterize TF occupancy preferences within aCNEs, we
used the human ENCODE TF binding sites (TFBS) dataset which
contains uniformly analyzed ChIP-seq binding profiles for 161
TFs in 91 cell types (Transcription Factor ChIP-seq Clusters V3
from ENCODE). We asked if any TF showed occupancy
enrichment within aCNEs compared to randomly selected open
chromatin regions (Supplementary Fig. 7a). Overall, DNA
binding factor enrichment in promoter and non-promoter aCNEs
were correlated (R= 0.8, P < 2.2e–16), with the top enriched
factors largely overlapping (Supplementary Fig. 7b–d). The
factors with the highest enrichment Z-scores were subunits of
PRC2 (EZH2, SUZ12) (Fig. 5b and Supplementary Fig. 7a, b).
Other transcriptional repressors (CTBP2, SIN3A, REST, KAP1)
or dual regulators (TCF7L2 and YY1, associated with both active
and repressive regulation in different contexts) were also seen
among the top 20 most enriched factors (Fig. 5b and
Supplementary Fig. 7a-d). We further observed significant
enrichment for a wide-variety of TFs (GATA2, FOXP2, NANOG)
and regulators of chromatin architecture (RAD21, CTCF) (Fig. 5b
and Supplementary Fig. 7a, b) suggesting that aCNEs play diverse
roles in gene regulation.
To gain a more comprehensive view of the tissue-specific usage
of aCNEs, we leveraged available chromatin states of 127 human
tissues/cell types that were predicted based on 5 chromatin marks
(H3K4me3, H3K4me1, H3K36me3, H3K27me3, and H3K9me3)
in the Roadmap Epigenomics Project48 (Fig. 5c and Supplemen-
tary Fig. 8). We simplified the 15 chromatin states into Active,
Bivalent, Polycomb repressed, Quiescent, and Other categories
ZaCNE1_hand2 (–109kb)
HaCNE1_HAND2 (–461kb)
a
c
b
d
ZaCNE20_tbx20 (–28kb)
HaCNE20_TBX20 (–78kb)
e
n
do
ge
no
us
  
ha
nd
2
Za
CN
E1
(gf
p)
H
aC
NE
1
(gf
p)
V
A
V
A
V
A
13 hpf 24 hpf 48 hpf
V
A
V
A
*
V
A
*
13 hpf 24 hpf 48 hpf
e
n
do
ge
no
us
  
tb
x2
0
Za
CN
E2
0
(gf
p)
H
aC
NE
20
(gf
p)
Tg(aCNE1:EGFP) stable lines           48 hpf Tg(aCNE20:EGFP) stable lines        48 hpf
GFP Overlay GFP Overlay
GFP Overlay
ventral
laterallateral
ventral
GFP Overlay
GFP Overlay
GFP Overlay
laterallateral
GFP Overlay
GFP OverlayGFP Overlay
ventral
laterallateral
GFP Overlay
GFP OverlayGFP Overlay
ventral
laterallateral
Fig. 4 Anciently conserved open chromatin regions share conserved cardiac activities. Fluorescent images (a, b) of aCNE transgenic lines generated using
zebrafish or human sequences. In-situ characterization (c, d) of the activities of the zebrafish (upper panel) and human (middle panel) aCNE sequences
and the endogenous expression of zebrafish cardiac genes (lower panel) nearby. In 48 hpf images in (c), black triangles indicate staining in ventricles and
red triangles staining in the inner curvature of atria for both aCNE1 transgenic lines. In 48 hpf images in (d), stars indicate the conserved activity of both
aCNE20 enhancers at the inner curvature of ventricles and atrioventricular canal regions and red triangles point to the staining in inflow tract. All images
shown were collected from embryos of stable lines and all scale bars represent 100 μm
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07451-z
8 NATURE COMMUNICATIONS |          (2018) 9:4977 | DOI: 10.1038/s41467-018-07451-z | www.nature.com/naturecommunications
(Fig. 5c and Supplementary Fig. 8). Only 10% (899/8865) of the
aCNEs showed constitutive activity (Active in >80% the tissues/
cell types) (Fig. 5d). Supporting this observation, aCNEs were
depleted for regions of constitutive activity compared to bulk
open chromatin regions (ENCODE3 human DNase I hypersen-
sitivity site Master list, P= 0.001, permutation test; Fig. 5d).
Supporting their function as lineage-restricted enhancers, we
found more than half of aCNEs to be active in a lineage-specific
manner (active chromatin state in at least one epigenome and
Polycomb repressed or Quiescent in > 70% of the epigenomes
(4603/8865), Fig. 5d, e). To examine if certain chromatin states
were enriched in aCNEs, we compared the percentage of a
c
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chromatin state among aCNEs to that among randomly selected
open chromatin regions in each epigenome. We found that
aCNEs were enriched for Bivalent (126/127 epigenomes) and
Polycomb repressed (121/127 epigenomes) chromatin and
depleted for Quiescent (120/127 epigenomes) and Other (119/
127 epigenomes) chromatin regions in the vast majority of the
epigenomes (Fig. 5f and Supplementary Fig. 8c). For Active
chromatin regions, aCNEs showed enrichment in some epigen-
omes (brain, neuronal cell types) but depletion in others (in
particular hematopoietic lineages) (Fig. 5f and Supplementary
Fig. 8c).
Given that lineage-specific activity and enrichment for PRC2
binding are well-established properties of poised enhancers in
ESCs49–51, we compared aCNEs to three enhancer types defined in
a recent study using mouse ESCs: poised (P300+, H3K27me3+,
H3K4me3−, H3K27ac−), primed (H3K4me1+, H3K4me3−,
H3K27ac−, H3K27me3−) and active (P300+, H3K27ac+,
H3K4me3−, H3K27me3−)51. Compared to all open chromatin
regions, aCNEs showed a five-fold enrichment for poised
enhancers (Bonferroni adjusted P= 8.87e–19, hypergeometric
test, one-sided) with little enrichment for active (1.4 fold,
Bonferroni adjusted P= 7.21e–3, hypergeometric test, one-sided)
or primed (1.1 fold, Bonferroni adjusted P= 1, hypergeometric
test, one-sided) enhancers. We also observed a strong enrichment
for poised enhancers that were identified in human ES cells (fold
of enrichment: 9.72, Bonferroni adjusted P= 1.14e–84, hypergeo-
metric test, one-sided)49.
Conserved genomic regulatory blocks (GRBs), which are
defined by cluster of CNEs, contain developmental genes,
coincide the boundaries of topologically associating domains
(TADs) and remain concordant between species of various
evolutionary distances52. We found that nearly 90% (7846/8866)
of human aCNEs fell into GRBs defined by using CNEs (70%
identity over 50 bp) between human and chicken52, suggesting
that aCNEs have been kept in a discrete set of syntenic regions
during vertebrate evolution. Overall, the genomic and epigenomic
properties of aCNEs suggest that many of them may serve as
lineage-restricted enhancers that facilitate the expression of
developmental genes.
Discussion
The existence of a phylotypic period implies that the gene reg-
ulatory events that control phylotypic gene expression patterns
are also likely to be evolutionarily constrained. In this study, we
characterized a population of cells enriched for cardiac progeni-
tors in early zebrafish embryos. By studying the open chromatin
regions in this population, we uncovered a set of putative
enhancers. Leveraging two resources that characterize non-coding
elements conserved between zebrafish and humans24,25 allowed
us to identify more than 6000 zebrafish open chromatin regions
that overlapped open chromatin regions in human or mouse
genomes. Of these conserved accessible chromatin regions
(aCNEs), 162 were unique to our cardiac progenitor-cell enriched
population. While 27% (43/162) of the orthologous human
regions have recently been predicted to be cardiac enhancers22, to
our knowledge none of these 162 zebrafish open chromatin
regions or their orthologous human or mouse sequences had been
previously tested in vivo. We found that 16/18 pre-phylotypic
aCNEs drove cardiac expression in stable zebrafish transgenic
lines at 24 hpf, which is around the time considered to be the
zebrafish phylotypic stage3,4,7, or later in development (48 hpf).
Further experiments, such as ChIP-seq for individual transcrip-
tion factors and posttranslational histone modifications will help
understand the spatial and temporal dynamics activity of these
aCNEs. Overall, our data support the existence of conserved cis-
regulatory elements that are primed early in development prior to
the establishment of the body plan and function during the
phylotypic stage.
Many functional CREs do not share overt sequence similarities
due to rapid turnover of the spacing between, and the sequences
of, TF binding motifs39,53–55. This phenomenon is prevalent even
within rodent56 or primate41 orders, let alone comparisons
between species separated over large evolutionary distances, such
as zebrafish and human (over 400 million years from the last
common ancestor). Nonetheless, sequence comparisons between
human and teleosts over great phylogenetic distance have dis-
covered many functional non-coding elements active during
development25,57–60 and CNEs are often found near genes
encoding developmental regulators24,25,57,59,61. More direct evi-
dence of conserved cis-regulatory events acting prior to the
phylotypic period have come from profiling epigenetic changes
around the phylotypic period. For example, a study using zeb-
rafish embryos has shown that regions dynamically gaining epi-
genetic modification indicative of development enhancers
(H3K27ac) at the gastrulation stage (8.5 hpf) are enriched for
evolutionarily conserved DNA sequences6. Furthermore, differ-
ential DNA methylation changes observed during the phylotypic
period in zebrafish, mouse, and frog were enriched for evolutio-
narily constrained DNA sequences and these DNA methylation
changes were presumably guided by prior sequence-specific
transcription binding events7,62. Our results identify a substantial
number of aCNEs that are established in the early embryo, many
Fig. 5 Genomics and epigenomic features of aCNEs. a Enrichment analysis of HaCNEs conserved with GFP+ or GFP− specific ATAC-seq peaks. Top 15
enrichment terms (binomial FDR < 0.5, FE > 2, sorted by binomial FDR) for each category (GFP+, GFP−) were plotted. Venn diagram shows the overlap of
genes associated with the GFP+ and GFP− specific HaCNEs that contribute to the top enrichment category (genes with H3K27me3 at promoters in ESC).
b DNA binding factor occupancy enrichment within all HaCNEs (n= 8866). Boxplots show the distribution of 1000 times permutation and red dots
represent the enrichment Z-scores normalized by the permutation results. The top 20 most enriched factors were plotted. c Heatmap showing the
chromatin states of 8865 HaCNEs across 127 epigenomes from Roadmap Epigenomics Project. One HaCNE on chromosome Y was excluded from this
analysis since it was absent in several epigenomes from female tissues. d Histogram showing the distribution of HaCNEs that displayed ACTIVE chromatin
states (x-axis). Approximately 10% of HaCNEs were constitutively active in the majority of the epigenomes (> 80%) (shaded area in histogram).
Compared to the same number of randomly selected open chromatin regions from the ENCODE3 human DHS master list, HaCNEs were depleted for
regions constitutively active (red dot on boxplot on the right). e Histogram of HaCNEs that displayed Quiescent or Polycomb repressed states.
f Enrichment of certain chromatin states (active, bivalent, polycomb repressed, quiescent and other) in HaCNEs compared to randomly selected open
regions (permutation). The enrichment Z-scores were plotted for each epigenome (red dot) along with the permutation distribution (boxplot)
(see Supplementary Methods for details). For each chromatin state, epigenomes with the top 10 (upper panel, most enriched/least depleted) and bottom
10 (lower panel, most depleted/least enriched) Z-scores were plotted. Row names were formatted as ID-EpigenomeName, which were retrieved from
Roadmap Epigenomics Project metadata table (http://egg2.wustl.edu/roadmap/web_portal/meta.html). In all boxplots, center represents median, lower
and higher hinges correspond to the first and third quartiles, and whiskers extend to values no further than 1.5 *(distance between first and third quantile)
from the hinges. Data beyond the end of whiskers are plotted individually as outliers
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of which drive tissue-specific gene expression patterns later in
development.
Vertebrate heart enhancers tend to show a lack of overt phy-
logenetic conservation relative to enhancers active in other tis-
sues, such as the brain, at the same developmental stages16,63. Our
results echo this finding, while at the same time highlighting a set
of highly conserved heart enhancers. By comparing open chro-
matin within CNEs identified using approaches such as transi-
tivity through a third species and ancestry reconstruction24,25, we
discovered 60% more conserved open chromatin regions between
zebrafish and human/mouse that would otherwise have been
missed by using direct sequence alignment alone (Fig. 3a, b).
Nearly half of the heart enhancers we validated were from
indirect sequence alignment (Supplementary Data 4), and
zebrafish-human aCNE orthologs identified from either direct
(aCNE1) or indirect (aCNE5, aCNE19, aCNE20) alignment share
conserved cardiac activity to a similar degree, despite a 50–60%
sequence identity. The aCNEs that we have validated can be used
to further our understanding of heart development and regen-
eration. For example, using one of these indirectly aligned heart
enhancers (aCNE21) we can recapitulate the endogenous
expression of the nearby cardiac gene hey264. Characterizing the
epigenomic landscape of additional cell-lineages early in devel-
opment will likely highlight further enhancers and reveal specific
aCNEs capable of driving cell or tissue-specific expression before,
during and after the phylotypic period.
Attesting to their potential importance in regulating specific
genes through long-range chromatin interactions, an established
genomic property of CNEs is that they cluster into regions of
conserved synteny, referred to as gene regulatory blocks (GRBs)65.
A significant fraction of GRB boundaries coincide with the
boundaries of topological association domains (TADs)52. We
found that nearly 90% (7846/8866) of our human aCNEs fell into
GRBs comprised of CNEs between human and chicken (70%
identity over 50 bp)52. Overall the genomic and epigenomic
properties of aCNEs suggest that many of them may serve as
lineage-restricted enhancers that facilitate the expression of
developmental genes.
We conclude that conserved open chromatin regions estab-
lished prior to the phylotypic period, and shared over 450 million
years of evolution, likely represent a set of ancient enhancers that
contribute to diverse spatial and temporal gene expression pat-
terns. Although the first deletions of ultraconserved non-coding
elements did not reveal overt phenotypes66, new studies are
beginning to demonstrate developmental anomalies67,68. Con-
sistent with the existence of shadow enhancers, which can buffer
the effects of individual enhancer loss69–71, two recent studies
showed that the pairwise deletion of ultraconserved enhancers
had an increased phenotypic impact68,71. While more work
remains to be done to dissect the in vivo, spatial-temporal
expression patterns and function of anciently conserved verte-
brate enhancers, regions of deeply conserved open chromatin
represent a solid foundation from which the regulation and
evolution of the vertebrate body plan can be explored.
Methods
Zebrafish husbandry and line maintenance. Zebrafish were maintained and
handled under the guidance and approval of the Canadian Council on Animal Care
and the Hospital for Sick Children Laboratory Animal Services. Embryos were
raised at 28.5 °C and developmentally staged by their morphology72. All zebrafish
lines used in the study were shown in Supplementary Method.
RNA probe synthesis and in-situ hybridization. EGFP sequence from the ZED
vector and Cre sequence from p3E-CreERT2 were sub-cloned into pGEM Teasy
vector (Promega, Cat# A1360) to make antisense probes (EGFP-F: GGATCCAT
GGTGAGCAAGGGCGAGGAG, EGFP-R: CTCGAGTTACTTGTACAGCT
CGTCCATGCCG; Cre-F: GGCGTTTTCTGAGCATACCTG, Cre-R: CCCAG
GCTAAGTGCCTTCTCT). DIG-labeled in-situ probes were synthesized using
DIG RNA Labeling kits (Roche). RNA in-situ hybridization was carried out using
the following protocol73. Briefly, embryos of the right stages were fixed in 4%
paraformaldehyde and then dehydrated in 100% MeOH. After rehydration,
embryos were permeabilized and incubated with digoxigenin-labeled antisense
RNA probe. RNA-probe hybrids were detected by an alkaline phosphatase-
conjugated antibody (Anti-Digoxigenin-AP, Fab Fragments, 1:5000, Roche, Cat#
11093274910) that catalyzed reaction on a chromogenic substrate. Stained embryos
were cleared in BBA solution (2:1 Benzyl benzoate: Benzyl alcohol) and imaged
under a Leica M205FA stereomicroscope
Immunostaining. Embryos from Tg (Smarcd3-F6: EGFP)hsc70 and Tg(nkx2.5:
ZsYellow)fb7 crosses were fixed at 13 hpf in 4% paraformaldehyde at 4 °C overnight.
After 3 × 5 min washes in PBS with 0.1% Triton, embryos were permeabilized in
PBS with 0.5% Triton for 4 h at room temperature (RT). Embryos were then
blocked in PBST (1% DMSO and 0.5% Triton X in PBS) with 5% Normal Goat
Serum (Millipore, Cat# S26-LITER) for 1.5–2 h at RT before being incubated with
primary antibodies (α-RCFP 1:500, Clontech Cat# 632475; α-GFP 1:1000, Ther-
moFisher Cat# A-11120) at 4 °C overnight. The Next day, embryos were washed
for 3–4 h in PBS with 0.1% Triton at RT, with 6–8 changes of solution. Incubation
of secondary antibodies (α-mouse IgG-FITC, 1:1000, Santa Cruz Cat# SC-2010; α-
rabbit IgG, Alex 568, 1:1000, ThermoFisher Cat# A-1101) was carried out at 4 °C
overnight, followed by the same washing procedure as that for primary antibodies.
After staining, embryos were mounted in 1% (w/v) low melt agarose (Sigma,
A9414) and imaged under a Nikon A1R Si Point Scanning Confocal microscope.
CreETR2 lineage tracing. Embryos from Tg (Smarcd3-F6:CreERT2)hsc76 and Tg
(βactin2:loxP-DsRed-STOP-loxP-EGFP)s928Tg crosses were dechorionated and
incubated in 5 μM 4-OH-Tamoxifen(4-HT, Sigma cat# T176) for 12 h. The time of
4-HT addition was specified in Supplementary Fig. 1. After treatment, embryos
were rinsed twice, placed in fresh egg water and imaged at 48 hpf under a Zeiss
Axio Zoom.V16 Stereoscope.
Embryo dissociation, fluorescence-activated cell sorting. Around 100 Tg
(Smarcd3-F6: EGFP)hsc70 embryos were dechorionated with pronase (Sigma, Cat#
11459643001) and transferred to a 1.5 mL Eppendorf tube when they reached the
bud stage. After incubation in 200 μl calcium-free Ringer solution (116 mM NaCl,
2.6 mM KCl, 5 mM HEPE, pH 7.0) for 5 min, embryos were transferred into a 24-
well plate with 500 μl TrypLE solution (GIBOCO, TrypLE Express Enzyme, cat #:
12604-013) for dissociation at room temperature. Embryos were gently homo-
genized every 5 min with P1000 tips. Dissociation was monitored under a dissec-
tion scope until most cells were in a single-cell suspension. The cell suspension was
transferred into 200 μl ice-cold fetal bovine serum (FBS) to stop the reaction. Cells
were centrifuged at 300 g for 3 min at 4 °C and washed with 500 μl ice-cold DMEM
with 10% FBS before resuspended in 500 μl ice-cold DMEM with 1% FBS. Right
before the Fluorescence-activated cell sorting (FACS), cells were filtered through a
40 μm strainer and DAPI was added at a concentration of 5 μg/ml to exclude dead
cells.
FACS was performed on Beckman Coulter Mo Flo XDP or Mo Flo Astrios
sorter, or Sony SH800S Cell Sorter with a 100 μm nozzle by the SickKids-UHN
Flow and Mass Cytometry Facility. Cell-doublets and dead cells were excluded
based on forward scatter, side scatter and DAPI channel. GFP+ and GFP− cells
were sorted into 100% FBS and subjected to RNA-seq or ATAC-seq procedures
immediately after sorting. Approximately 30,000–50,000 GFP+ cells and 100,000
GFP− cells were collected in one FACS run.
Bulk mRNA-seq and single-cell mRNA-seq. Single-cell cDNA libraries were
prepared using Fluidigm C1 system. After FACS, GFP+ cells were washed twice in
DMEM with 3% FBS and filtered through a 40 μm cell strainer. Cells were adjusted
to a concentration of 400–500 cells/μl and mixed with C1 suspension solution at a
5.2:4.8 ratio. 10 μl of the final cell mixture was loaded into a C1 medium or small
Chip. Cell capture was examined under a microscope and only wells with a single
cell captured were included in library construction. 3 ArrayControl™ RNA Spikes
were added into the cell lysis mixture according to the Fluidigm C1 single-cell
mRNA-seq protocol (PN 100–7168 Rev. B1). Cell lysis, Oligo-dT primer mediated
reverse transcription, 21 cycles of PCR amplification and cDNA harvesting were
performed as per manufacturer's instruction (Fluidigm, PN 100–7168 Rev. B1). We
usually recovered 30–40 cells (30–40% capture efficiency) from one C1 Chip and
96 single-cell cDNA libraries were collected from three batches of experiments.
For bulk mRNA-seq, RNA from 4000 GFP+ or GFP− cells were prepared
using RNeasy Plus Micro Kit (Qiagen, Cat# 74034) and cDNA libraries were
prepared following the Fluidigm tube control protocol (the same protocol as that
for single-cell mRNA-seq except the input cell number is different). Three
biological replicates were collected for both GFP+ and GFP− samples.
For both single-cell and bulk mRNA-seq, final sequencing libraries were made
using Nextera XT DNA Sample Preparation Kit (Illumina, Cat# FC-131–1096) and
120 bp pair-end sequenced on an Illumina HiSeq 2500 platform according to
manufacturer’s instruction. Bulk RNA-seq libraries were sequenced to a depth of
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(18 ± 1.9) million reads and single-cell mRNA-seq libraries a depth of (3.0 ± 0.7)
million reads.
ATAC-seq. ATAC-seq was performed with minor modifications to the published
protocol74. 30,000–50,000 cells obtained from FACS were used for nuclei prep.
After tagmentation, transposed DNA fragments were amplified using the following
PCR condition (1 cycle of 72 °C for 5 min and 98 °C for 30 s, followed by 12 cycles
of 98 °C for 10 s, 63 °C for 30 s and 72 °C for 1 min). Amplified libraries were
purified twice with Agencourt Ampure XP beads (Beckman Coulter, Cat#A63880)
with a bead-to-sample ratio of 1.8:1. A Qubit fluorometer and Aglient Bioanalyzer
were used to check library quality and concentration. Libraries were 50 bp single-
end sequenced on Illumina HiSeq 2500 platform to a depth of (3.5–7.0) × 107
reads. Two biological replicates were collected for both GFP+ and GFP− cells.
Transgenic zebrafish enhancer assay. Candidate regions containing the zebra-
fish ATAC-seq peaks (21 ZaCNEs) or human DHSs (4 HaCNEs) were amplified
from genomic DNA and recombined into pDONOR221 vector (Invitrogen, Gate-
way BP Clonase II Enzyme Mix, Cat# 11789020) before they were cloned into E1b-
Tol2-GFP-gw vector. 25 ng E1b-Tol2-GFP-gw plasmid carrying one aCNE and 150
ng Tol2 mRNA were injected into wild-type embryos at one-cell stage. F0 founder
embryos were raised to 48–52 hpf before imaging and heart expression scoring.
Candidate regions were considered as a heart enhancer if more than 30% of the
injected embryos displayed GFP+ cells beating in the hearts, which was consistent
with the criterion used in similar studies before75. 42–220 (average n= 86) injected
embryos were analyzed for each candidate region. The genomic coordinates,
lengths and nearby genes of candidate regions and primers used for cloning can be
seen in the Supplementary Data 4.
F0 embryos injected with enhancers that passed the 30% threshold were raised
to screen for transgene germline carriers. Except enhancer ZaCNE18 for which
only one carrier has been identified, 2–4 independent alleles have been identified
for each enhancer (see Supplementary Data 4). Though ectopic expression has been
seen in some carriers, the cardiac expression patterns were similar in different
alleles of the same transgene.
GATA motif mutagenesis. GATA motif mutation was introduced by primers
designed by Agilent Genomics QuickChange program (http://www.genomics.
agilent.com/primerDesignProgram.jsp) (ZaCNE1_muta_F:
cagattaggacccagctaggtgccagtggggggggtgttagtgcagaaaaggttacactac;
ZaCNE1_muta_R:
gtagtgtaaccttttctgcactaacaccccccccactggcacctagctgggtcctaatctg; HaCNE1_muta_F:
attagagtgaaaagaggtgccggtggggggggtgcgaatgcgccaggggtcacgc;
HaCNE1_muta_R: gcgtgacccctggcgcattcgcaccccccccaccggcacctcttttcactctaat).
The primers were designed to convert the aligned GATA consensus sequence
AGATAA to CCCCCC. pDONOR221 vectors carrying the mutated aCNE1
enhancers were PCR amplified from the original pDONOR221 containing the wild-
type aCNE1 sequences using the primers above. After amplification, 50 μl PCR
mixture was incubated with 1 μl DpnI (NEB, Cat#R0176S) at 37 °C to remove wild-
type enhancer templates. DpnI was inactivated at 80 °C for 20 min before
transformation. Plasmid clones with the correct GATA motif mutation were
confirmed by Sanger sequencing and used as entry clones to make E1b-Tol2-GFP
constructs containing mutated aCNE1 enhancers. Independent germline carriers
have been identified for ZaCNE1_GATAMutated (n= 5) and
HaCNE1_GATAMutated (n= 4) enhancers (see Supplementary Data 4). GFP
expression levels in different GATA_Mutated alleles look slightly different but were
generally weaker than wildtype_alleles. Images in Supplementary Fig. 6 were taken
using alleles showing median expression level within all alleles.
Analyses of mRNA-seq and ATAC-seq data. Analysis pipelines of mRNA-seq
and ATAC-seq data are shown in Supplementary Methods.
Identification of sequence-conserved open regions. Two zebrafish CNE datasets
were used for this analysis. First, Zebrafish CNEs (zCNEs) conserved with human
or mouse identified from Hiller et al.24 were obtained from the authors, including
records of direct sequence alignment and transitive mapping through other species
or reconstructed ancestries24. zCNEs that overlaps a zebrafish-human well-aligning
window24 by at least 15 bp were defined as directly aligned. zCNEs that can be
mapped back to mouse through transitive alignment or ancestry reconstruction but
cannot be detected by direct alignment were defined as indirectly aligned CNEs.
The same direct and indirect alignment definition was set for zCNE conserved with
mouse (zCNE_mouse)
To include more high-quality zebrafish CNEs into our analysis, we used another
zebrafish-human CNE dataset identified in a recent study through transitive
alignment via the spotted gar genome25, which we referred to as garCNE. If the
zebrafish coordinate of a garCNE does not overlap any zCNE records, we added it
into our analysis and define it as indirectly aligned. Altogether, we collect 20,005
zebrafish CNEs conserved with human, with 10187 direct and 9818 indirect ones
(Supplementary Table 1).
To establish the same system for CNEs conserved between zebrafish and mouse,
we used liftOver to convert the human-zebrafish CNEs identified through gar
genome to mouse-zebrafish CNEs (-minMatch= 0.1), and then add those CNEs
on top of zCNE_mouse dataset in a similar way as what we did for human. At the
end we obtained 18,827 zebrafish CNEs conserved with mouse, with 9429 direct
and 9399 indirect ones (Supplementary Table 1). Finally, we associated zebrafish
ATAC-seq peaks to CNEs (sequence-conserved ATAC-seq peaks) if they overlap a
CNE by at least one base pair. Nearly 90% of the these CNE-associated ATAC-seq
peaks were completely excluded from gene coding regions defined by Ensembl
transcriptome annotation (Zv9, release 79).
Identification of aCNEs. Human or mouse DNase master peak lists from
ENCODE342 (hg19: ENCFF257KON; mm10: ENCFF203SGZ) were used for
identifying open regions anciently conserved between zebrafish and human or
between zebrafish and mouse. Mouse DNase master peaks, which were provided as
mm10 coordinates, were converted to mm9 coordinates using liftOver (-min-
Match= 0.95). If a CNE that overlaps a zebrafish ATAC-seq peak by at least one
base pair also overlaps a DNase I hypersensitivity site (DHS) from the DNase
master lists by at least one base pair, then this orthologous ATAC-seq peak and
DHS linked via CNEs are identified as accessible CNEs (aCNEs).
There are 1,199,722 non-overlapping regions in mouse DHSs master list after
liftOver, 4,193,929 non-overlapping regions in human DHS master list
(Supplementary Table 3). Probably due to the total number differences, more
human DHSs have been identified as aCNEs than mouse DHSs; similarly, more
ATAC-seq peaks were identified as aCNEs shared with human than with mouse
(Supplementary Table 3).
We found analyses with the DHS master lists sometimes gave us a chain of
DHSs that are conserved with the same ATAC-seq peaks. To avoid potential bias
that may be introduced in analysis conducted by GREAT, we merged the DHSs
that are within 200 bp and conserved with the same ATAC-seq peaks. We used
merged DHSs for analyses in Fig. 5a, Supplementary Figs. 3f, 7b, c. All other
analyses were conducted on original DHS coordinates.
Comparative genomic analyses of aCNEs are shown in Supplementary
Methods.
Data availability
ATAC-seq and RNA-seq data are available at ArraryExpress under the accession
number E-MTAB-6078 and E-MTAB-6077. All other relevant data supporting the
key findings of this study are available within the article and its Supplementary
Information files or from the corresponding author upon reasonable request.
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